Skip to main content
Erschienen in: European Journal of Pediatrics 5/2020

02.01.2020 | Original Article

Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years

verfasst von: Engy A. Mogahed, Al-Hussien A. Sayed, Sara E. Khalifa, Ahmed El-Hennawy, Mona S. El-Raziky

Erschienen in: European Journal of Pediatrics | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to detect etiologies and histopathological features of non-alcoholic fatty liver disease (NAFLD) in Egyptian children < 10 years from hepatologist perspectives. Infants and children below 10 years of age with biopsy-proven fatty liver over a 6-year period were included. NAFLD activity score was used to detect the presence of non-alcoholic steatohepatitis (NASH). The study included 66 cases whose age ranged between 5 months and 10 years. Transaminases were elevated in 60% patients. Glycogen storage disease (GSD) was the most common diagnosis (33.3%) followed by hepatitis C virus (HCV) (10.6%) and Chanarin-Dorfman syndrome (CDS) (9.1%). The cause of steatosis could not be identified in 28.8% of cases. There was a higher prevalence of secondary causes of NAFLD in patients < 10 years. Liver histopathological examination revealed preserved lobular architecture in 75.7% with minimal-to-mild fibrosis in 79%. Steatosis was macrovesicular in all specimens (severe steatosis in 39.4%). Four patients had NASH. Higher degree of steatosis was associated with more severe fibrosis (P = 0.01).
Conclusion: GSD was the commonest cause of secondary NAFLD in Egyptian children < 10 years followed by HCV and CDS with higher degrees of steatosis in younger patients. The degree of fibrosis was significantly related to the degree of steatosis.
What is Known:
Primary non-alcoholic fatty liver disease (NAFLD) is rare in children aged less than 10 years.
Secondary causes of NAFLD should be considered in patients who do not have traditional risk factors.
What is New:
Glycogen storage disease, hepatitis C virus, and Chanarin-Dorfman syndrome are the commonest causes of secondary NAFLD in Egyptian children (< 10 years) with higher degrees of steatosis in younger patients.
The degree of liver fibrosis is significantly related to the degree of steatosis.
Literatur
1.
Zurück zum Zitat Vajro P, Lenta S, Socha P (2012) Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 4:700–713CrossRef Vajro P, Lenta S, Socha P (2012) Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 4:700–713CrossRef
2.
Zurück zum Zitat Janczyk W, Socha P (2012) Non-alcoholic fatty liver disease in children. Clin Res Hepatol Gastroenterol 36:297–300CrossRef Janczyk W, Socha P (2012) Non-alcoholic fatty liver disease in children. Clin Res Hepatol Gastroenterol 36:297–300CrossRef
3.
Zurück zum Zitat Kneeman JM, Misdraji J, Corey KE (2012) Secondary causes of nonalcoholic fatty liver disease. Ther Adv Gastroenterol 5:199–207CrossRef Kneeman JM, Misdraji J, Corey KE (2012) Secondary causes of nonalcoholic fatty liver disease. Ther Adv Gastroenterol 5:199–207CrossRef
4.
Zurück zum Zitat De Bruyne RML, Fitzpatrick E, Dhawan A (2010) Fatty liver disease in children: eat now pay later. Hepatol Int 4:375–385CrossRef De Bruyne RML, Fitzpatrick E, Dhawan A (2010) Fatty liver disease in children: eat now pay later. Hepatol Int 4:375–385CrossRef
5.
Zurück zum Zitat Yang M, Gong S, Ye SQ, Lyman B, Geng L, Chen P, Li DY (2014) Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 6:4691–4705CrossRef Yang M, Gong S, Ye SQ, Lyman B, Geng L, Chen P, Li DY (2014) Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 6:4691–4705CrossRef
6.
Zurück zum Zitat Juluri R, Vuppalanchi R, Olson J, Ünalp A, Van Natta ML, Cummings OW, Tonascia J (2011) Generalizability of the NASH CRN histological scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 45:55–58CrossRef Juluri R, Vuppalanchi R, Olson J, Ünalp A, Van Natta ML, Cummings OW, Tonascia J (2011) Generalizability of the NASH CRN histological scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 45:55–58CrossRef
7.
Zurück zum Zitat Knoppke B, Pfister ED, Grothues D, Vermehren J, Rauschenfels S, Melter M (2006) Causes of non-alcoholic fatty liver disease (NAFLD) in infant and children. J Pediatr Gastroenterol Nutr 42:1–110CrossRef Knoppke B, Pfister ED, Grothues D, Vermehren J, Rauschenfels S, Melter M (2006) Causes of non-alcoholic fatty liver disease (NAFLD) in infant and children. J Pediatr Gastroenterol Nutr 42:1–110CrossRef
8.
Zurück zum Zitat Temple CP, Li J, Nguyen V, Oben JA (2016) A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 16:1–7 Temple CP, Li J, Nguyen V, Oben JA (2016) A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 16:1–7
10.
Zurück zum Zitat Wendy AH, Jordan FH, Colleen MH (2009) Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patients. Pediatr Infect Dis J 28:724–772CrossRef Wendy AH, Jordan FH, Colleen MH (2009) Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patients. Pediatr Infect Dis J 28:724–772CrossRef
11.
Zurück zum Zitat Mitra S, Samanta M, Sarkar M, Chatterjee S (2010) Dorfman-Chanarin syndrome: a rare neutral lipid storage disease. Indian J Pathol Microbiol 53:799–801CrossRef Mitra S, Samanta M, Sarkar M, Chatterjee S (2010) Dorfman-Chanarin syndrome: a rare neutral lipid storage disease. Indian J Pathol Microbiol 53:799–801CrossRef
12.
Zurück zum Zitat Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, Chung WK, Desai DM, el-Gharbawy A, Haller R, Smit GP, Smith AD, Hobson-Webb LD, Wechsler SB, Weinstein DA, Watson MS, ACMG (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12:446–463CrossRef Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, Chung WK, Desai DM, el-Gharbawy A, Haller R, Smit GP, Smith AD, Hobson-Webb LD, Wechsler SB, Weinstein DA, Watson MS, ACMG (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12:446–463CrossRef
14.
Zurück zum Zitat El-Karaksy AG, El-Raziky M, Mogahed E, Fateen E, Gouda A et al (2014) Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study. Arab J Gastroenterol 15:63–67CrossRef El-Karaksy AG, El-Raziky M, Mogahed E, Fateen E, Gouda A et al (2014) Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study. Arab J Gastroenterol 15:63–67CrossRef
15.
Zurück zum Zitat Gomaa A, Allam N, Elsharkway A, El Kassas M, Waked I (2017) Hepatitis C infection in Egypt: prevalence, impact and management strategies. Hepat 9:17–25 Gomaa A, Allam N, Elsharkway A, El Kassas M, Waked I (2017) Hepatitis C infection in Egypt: prevalence, impact and management strategies. Hepat 9:17–25
16.
Zurück zum Zitat El-Zanaty and Associates [Egypt], and ICF International (2015) Egypt health issues survey 2015. Ministry of Health and Population and ICF International, Cairo, and Rockville El-Zanaty and Associates [Egypt], and ICF International (2015) Egypt health issues survey 2015. Ministry of Health and Population and ICF International, Cairo, and Rockville
17.
Zurück zum Zitat Patel V, Sanyal AJ (2013) Drug-induced steatohepatitis. Clin Liver Dis 17:533–537CrossRef Patel V, Sanyal AJ (2013) Drug-induced steatohepatitis. Clin Liver Dis 17:533–537CrossRef
18.
Zurück zum Zitat Kamal SM, Nasser IA (2008) Hepatitis C genotype 4: what we know and what we don’t yet know. Hepatology 47:1371–1383CrossRef Kamal SM, Nasser IA (2008) Hepatitis C genotype 4: what we know and what we don’t yet know. Hepatology 47:1371–1383CrossRef
19.
Zurück zum Zitat Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Petraki K, Hadziyannis E, Pandelidaki H, Zafiropoulou R, Savvas S, Koskinas J, Archimandritis AJ (2007) Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors. Am J Gastroenterol 102:634–641CrossRef Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Petraki K, Hadziyannis E, Pandelidaki H, Zafiropoulou R, Savvas S, Koskinas J, Archimandritis AJ (2007) Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors. Am J Gastroenterol 102:634–641CrossRef
20.
Zurück zum Zitat Zayadi A, Attia M, Barakat EM, Zalata K, Saeid A, Hamdy H et al (2007) Non-alcoholic fatty liver disease in patients with HCV genotype 4. Gut 56:1170–1171CrossRef Zayadi A, Attia M, Barakat EM, Zalata K, Saeid A, Hamdy H et al (2007) Non-alcoholic fatty liver disease in patients with HCV genotype 4. Gut 56:1170–1171CrossRef
21.
Zurück zum Zitat Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group (2006) HCV Meta-Analysis (on) Individual Patients’ Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130:1636–1642CrossRef Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group (2006) HCV Meta-Analysis (on) Individual Patients’ Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130:1636–1642CrossRef
22.
Zurück zum Zitat Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y et al (2002) Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J16:185–194CrossRef Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y et al (2002) Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J16:185–194CrossRef
23.
Zurück zum Zitat Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358–1364CrossRef Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358–1364CrossRef
24.
Zurück zum Zitat Kralj D, Virovic JL, Stojsavljevic S, Duvnjak M, Smolic M, Curcic IB (2016) Hepatitis C virus, insulin resistance, and steatosis. J Clin Transl Hepatol 4:66–75CrossRef Kralj D, Virovic JL, Stojsavljevic S, Duvnjak M, Smolic M, Curcic IB (2016) Hepatitis C virus, insulin resistance, and steatosis. J Clin Transl Hepatol 4:66–75CrossRef
25.
Zurück zum Zitat Arslansoyu ÇS, Gençpınar P, Makay B, Yüzbaşıoğlu B (2013) Chanarin-Dorfman syndrome with multi-system involvement in two siblings. Turk J Haematol 30:72–75CrossRef Arslansoyu ÇS, Gençpınar P, Makay B, Yüzbaşıoğlu B (2013) Chanarin-Dorfman syndrome with multi-system involvement in two siblings. Turk J Haematol 30:72–75CrossRef
26.
Zurück zum Zitat Moses SW, Potashnik R, Moran A, Peleg N, Bashan N (1990) Hexose uptake and transport in polymorphonuclear leukocytes from patients with glycogen storage disease Ib. Pediatr Res 28:19–23CrossRef Moses SW, Potashnik R, Moran A, Peleg N, Bashan N (1990) Hexose uptake and transport in polymorphonuclear leukocytes from patients with glycogen storage disease Ib. Pediatr Res 28:19–23CrossRef
27.
Zurück zum Zitat Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE (2003) Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143:500–505CrossRef Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE (2003) Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143:500–505CrossRef
28.
Zurück zum Zitat Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H (2008) Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 55:1433–1438PubMed Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H (2008) Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 55:1433–1438PubMed
29.
Zurück zum Zitat Lucchiari S, Pagliarani S, Ulzi G, Violano R, Ripolone M, Bordoni A, Nizzardo M, Gatti S, Corti S, Moggio M, Bresolin N, Comi GP (2014) Glycogen storage disease type III: a novel Agl knockout mouse model. Biochim Biophys Acta 1842:2318–2328CrossRef Lucchiari S, Pagliarani S, Ulzi G, Violano R, Ripolone M, Bordoni A, Nizzardo M, Gatti S, Corti S, Moggio M, Bresolin N, Comi GP (2014) Glycogen storage disease type III: a novel Agl knockout mouse model. Biochim Biophys Acta 1842:2318–2328CrossRef
30.
Zurück zum Zitat Squires JE, Balistreri WF (2017) Hepatitis C virus infection in children and adolescents. Hep Comm 2:87–98CrossRef Squires JE, Balistreri WF (2017) Hepatitis C virus infection in children and adolescents. Hep Comm 2:87–98CrossRef
31.
Zurück zum Zitat Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51:1061–1067CrossRef Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51:1061–1067CrossRef
32.
Zurück zum Zitat Mogahed EA, El-Hennawy A, El-Sayed R, El-Karaksy H (2015) Chanarin-Dorfman syndrome: a case report and review of the literature. Arab J Gastroenterol 16:142–144CrossRef Mogahed EA, El-Hennawy A, El-Sayed R, El-Karaksy H (2015) Chanarin-Dorfman syndrome: a case report and review of the literature. Arab J Gastroenterol 16:142–144CrossRef
33.
Zurück zum Zitat Gupta N, Gothwal S, Satpathy AK, Missaglia S, Tavian D, Das P, Timila D, Kabra M (2016) Chanarin Dorfman syndrome: a case report with novel nonsense mutation. Gene 575:359–362CrossRef Gupta N, Gothwal S, Satpathy AK, Missaglia S, Tavian D, Das P, Timila D, Kabra M (2016) Chanarin Dorfman syndrome: a case report with novel nonsense mutation. Gene 575:359–362CrossRef
34.
Zurück zum Zitat Hourigan SK, Torbenson M, Tibesar E, Scheimann AO (2015) The full spectrum of hepatic steatosis in children. Clinped 7:635–642 Hourigan SK, Torbenson M, Tibesar E, Scheimann AO (2015) The full spectrum of hepatic steatosis in children. Clinped 7:635–642
35.
Zurück zum Zitat Gogus S, Kocak N, Gonen C, Ciliv KE, Akc Z, Oren A, Kale G (2002) Histologic features of the liver in type Ia glycogen storage disease: comparative study between different age groups and consecutive biopsies. Pediatr Dev Pathol 5:299–304CrossRef Gogus S, Kocak N, Gonen C, Ciliv KE, Akc Z, Oren A, Kale G (2002) Histologic features of the liver in type Ia glycogen storage disease: comparative study between different age groups and consecutive biopsies. Pediatr Dev Pathol 5:299–304CrossRef
36.
Zurück zum Zitat Redaelli C, Coleman RA, Moro L, Dacou-Voutetakis C, Elsayed SM, Prati D, Colli A, Mela D, Colombo R, Email DT (2010) Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis 5:33CrossRef Redaelli C, Coleman RA, Moro L, Dacou-Voutetakis C, Elsayed SM, Prati D, Colli A, Mela D, Colombo R, Email DT (2010) Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis 5:33CrossRef
37.
Zurück zum Zitat Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195–203CrossRef Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195–203CrossRef
38.
Zurück zum Zitat Ersoy Ö, Alkım C, Onuk MD, Demirsoy H, Argon D (2011) A rare cause of fatty liver and elevated aminotransferase levels: Chanarin-Dorfman syndrome: a case report. Int J Hepatol 2011:341372CrossRef Ersoy Ö, Alkım C, Onuk MD, Demirsoy H, Argon D (2011) A rare cause of fatty liver and elevated aminotransferase levels: Chanarin-Dorfman syndrome: a case report. Int J Hepatol 2011:341372CrossRef
39.
Zurück zum Zitat Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, Vallone G, Meli R (2011) Effects of lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 52:740–743CrossRef Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, Vallone G, Meli R (2011) Effects of lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 52:740–743CrossRef
40.
Zurück zum Zitat Burgert TS, Taksali SE, Dziura J (2006) Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91:4287–4294CrossRef Burgert TS, Taksali SE, Dziura J (2006) Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91:4287–4294CrossRef
Metadaten
Titel
Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years
verfasst von
Engy A. Mogahed
Al-Hussien A. Sayed
Sara E. Khalifa
Ahmed El-Hennawy
Mona S. El-Raziky
Publikationsdatum
02.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 5/2020
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-019-03551-0

Weitere Artikel der Ausgabe 5/2020

European Journal of Pediatrics 5/2020 Zur Ausgabe

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.